Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bagegni

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advances in Cancer Research|April 4, 2020
Age-related disparities in older women with breast cancerNusayba A Bagegni, Lindsay L Peterson
Cancers|December 30, 2025
HER2-Low and HER2-Ultralow Metastatic Breast Cancer and Trastuzumab Deruxtecan: Common Clinical Questions and AnswersNusayba A Bagegni, Karthik V Giridhar, Daphne Stewart
Plos One|September 20, 2019
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer DatabaseNusayba A Bagegni, Yu Tao, Foluso O Ademuyiwa
The British Journal of Ophthalmology|October 1, 1988
Visual recovery in orbital vasculitisA Bagegni, R W Lyness, P B Johnston, et al.
International Ophthalmology|July 1, 1990
Orbital infiltration by eyelid skin carcinomaW M Amoaku, A Bagegni, W C Logan, et al.
Breast Cancer (Dove Medical Press)|May 6, 2022
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on PembrolizumabNusayba A Bagegni, Andrew A Davis, Katherine K Clifton, et al.
Journal of Molecular Biology|November 13, 2007
Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustmentRajagopalan Bhaskaran, Mark O Palmier, Nusayba A Bagegni, et al.
Oncology and Therapy|November 20, 2021
Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the LiteratureMegan L Kruse, Irene M Kang, Nusayba A Bagegni, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2025
Long-Term Results of a Phase II Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone Positive Breast CancerDavid S Lakomy, William R Kennedy, Eric Laugeman, et al.
Practical Radiation Oncology|June 9, 2026
Tri-APBI: Single Institution Phase I/II Prospective Clinical Trial of Three Fraction Accelerated Partial Breast Irradiation for Stage 0-I Breast CancerWilliam R Kennedy, Silpa Raju-Salicki, Maria A Thomas, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Cancer Research|April 4, 2020
Age-related disparities in older women with breast cancerNusayba A Bagegni, Lindsay L Peterson
Cancers|December 30, 2025
HER2-Low and HER2-Ultralow Metastatic Breast Cancer and Trastuzumab Deruxtecan: Common Clinical Questions and AnswersNusayba A Bagegni, Karthik V Giridhar, Daphne Stewart
Plos One|September 20, 2019
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer DatabaseNusayba A Bagegni, Yu Tao, Foluso O Ademuyiwa
The British Journal of Ophthalmology|October 1, 1988
Visual recovery in orbital vasculitisA Bagegni, R W Lyness, P B Johnston, et al.
International Ophthalmology|July 1, 1990
Orbital infiltration by eyelid skin carcinomaW M Amoaku, A Bagegni, W C Logan, et al.
Breast Cancer (Dove Medical Press)|May 6, 2022
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on PembrolizumabNusayba A Bagegni, Andrew A Davis, Katherine K Clifton, et al.
Journal of Molecular Biology|November 13, 2007
Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustmentRajagopalan Bhaskaran, Mark O Palmier, Nusayba A Bagegni, et al.
Oncology and Therapy|November 20, 2021
Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the LiteratureMegan L Kruse, Irene M Kang, Nusayba A Bagegni, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2025
Long-Term Results of a Phase II Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone Positive Breast CancerDavid S Lakomy, William R Kennedy, Eric Laugeman, et al.
Practical Radiation Oncology|June 9, 2026
Tri-APBI: Single Institution Phase I/II Prospective Clinical Trial of Three Fraction Accelerated Partial Breast Irradiation for Stage 0-I Breast CancerWilliam R Kennedy, Silpa Raju-Salicki, Maria A Thomas, et al.
Pageof 2